Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in Clinical & Translational Immunology
- Vol. 9 (7), e1160
- https://doi.org/10.1002/cti2.1160
Abstract
Objectives A wide range of duration of viral RNA shedding in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has been observed. We aimed to investigate factors associated with prolonged and intermittent viral RNA shedding in a retrospective cohort of symptomatic COVID‐19 patients. Methods Demographic, clinical and laboratory data from hospitalised COVID‐19 patients from a single centre with two consecutive negative respiratory reverse transcription‐polymerase chain reaction (RT‐PCR) results were extracted from electronic medical records. Kaplan–Meier survival curve analysis was used to assess the effect of clinical characteristics on the duration and pattern of shedding. Plasma levels of immune mediators were measured using Luminex multiplex microbead‐based immunoassay. Results There were 201 symptomatic patients included. Median age was 49 years (interquartile range 16–61), and 52.2% were male. Median RNA shedding was 14 days (IQR 9–18). Intermittent shedding was observed in 77 (38.3%). We did not identify any factor associated with prolonged or intermittent viral RNA shedding. Duration of shedding was inversely correlated with plasma levels of T‐cell cytokines IL‐1β and IL‐17A at the initial phase of infection, and patients had lower levels of pro‐inflammatory cytokines during intermittent shedding. Conclusions Less active T‐cell responses at the initial phase of infection were associated with prolonged viral RNA shedding, suggesting that early immune responses are beneficial to control viral load and prevent viral RNA shedding. Intermittent shedding is common and may explain re‐detection of viral RNA in recovered patients.Keywords
Funding Information
- A*STAR COVID-19 Research funding (H/20/04/g1/006)
- National Medical Research Council COVID19 Research Fund (COVID19RF-001)
- National Research Foundation Grant (NRF2017_SISFP09)
This publication has 31 references indexed in Scilit:
- The Role of Cyclooxygenase in Multiplication and Reactivation of HSV-1 in Vestibular Ganglion NeuronsThe Scientific World Journal, 2014
- Model Updating of Complex Structures Using the Combination of Component Mode Synthesis and Kriging PredictorThe Scientific World Journal, 2014
- Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in miceJCI Insight, 2011
- Epithelial EGF receptor signaling mediates airway hyperreactivity and remodeling in a mouse model of chronic asthmaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infectionLiver International, 2010
- Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood productsTransfusion, 2006
- IL-1β, but not IL-1α, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responsesInternational Immunology, 2006
- Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARSRespiratory Research, 2005
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004
- Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyThe Lancet, 2003